Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II randomized single-blind study of XH-S003 capsules in paroxysmal nocturnal hemoglobinuria
CTR20251226Phase 2Completed
- Sponsor
- Xinghao Pengbo
- Start
- Apr 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of XH-S003 in paroxysmal nocturnal hemoglobinuria (PNH), sponsored by Xinghao Pengbo. Started Apr 2025; status: completed.
02
Drugs
XH-S003
03
Conditions
paroxysmal nocturnal hemoglobinuria (PNH)
Beyond the preview
Go deeper on CTR20251226.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20251226.